Cargando…

“Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study

OBJECTIVE: To understand and report on the nature of patient group interactions with the pharmaceutical industry from the perspective of patient group representatives by exploring the range of attitudes towards pharmaceutical industry sponsorship and how, why, and when interactions occur. DESIGN: Em...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parker, Lisa, Fabbri, Alice, Grundy, Quinn, Mintzes, Barbara, Bero, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190020/ https://www.ncbi.nlm.nih.gov/pubmed/31831471 http://dx.doi.org/10.1136/bmj.l6694

Ejemplares similares

‘Lines in the sand’: an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders
por: Parker, Lisa, et al.
Publicado: (2021)

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and overactive bladder syndrome? An Australian cohort study
por: Mintzes, Barbara, et al.
Publicado: (2018)

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia
por: Fabbri, Alice, et al.
Publicado: (2017)

Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study
por: Pokorny, Adrian M J, et al.
Publicado: (2023)

Risky business? Pharmaceutical industry sponsorship of health consumer groups
por: Bero, Lisa A, et al.
Publicado: (2021)

Association Between Conflicts of Interest and Authors’ Positions on Harms of Varenicline: a Cross-Sectional Analysis
por: Fabbri, Alice, et al.
Publicado: (2021)

Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study
por: Karanges, Emily Aspasia, et al.
Publicado: (2021)

Interactions between Non-Physician Clinicians and Industry: A Systematic Review
por: Grundy, Quinn, et al.
Publicado: (2013)

The "Hot Potato" of Mental Health App Regulation: A Critical Case Study of the Australian Policy Arena
por: Parker, Lisa, et al.
Publicado: (2018)

Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study
por: Parker, Lisa, et al.
Publicado: (2019)

Health promoter, advocate, legitimiser — the many roles of WHO guidelines: a qualitative study
por: Wang, Zhicheng, et al.
Publicado: (2019)

Variations in processes for guideline adaptation: a qualitative study of World Health Organization staff experiences in implementing guidelines
por: Wang, Zhicheng, et al.
Publicado: (2020)

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
por: Fabbri, Alice, et al.
Publicado: (2018)

Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?
por: Kanavos, Panos, et al.
Publicado: (2014)

A health app developer’s guide to law and policy: a multi-sector policy analysis
por: Parker, Lisa, et al.
Publicado: (2017)

Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
por: Robertson, Jane, et al.
Publicado: (2009)

"It’s Not Smooth Sailing": Bridging the Gap Between Methods and Content Expertise in Public Health Guideline Development
por: Chartres, Nicholas, et al.
Publicado: (2020)

Medical, pharmacy and nursing students in the Baltic countries: interactions with the pharmaceutical and medical device industries
por: Salmane-Kulikovska, Ieva, et al.
Publicado: (2020)

Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest
por: Bero, Lisa A., et al.
Publicado: (2016)

Correction to: Medical, pharmacy and nursing students in the Baltic countries: interactions with the pharmaceutical and medical device industries
por: Salmane-Kulikovska, Ieva, et al.
Publicado: (2020)

Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study
por: Behdarvand, Behrad, et al.
Publicado: (2019)

‘Spin’ in published biomedical literature: A methodological systematic review
por: Chiu, Kellia, et al.
Publicado: (2017)

The SSSPIN study—spin in studies of spin: meta-research analysis
por: Bero, Lisa, et al.
Publicado: (2019)

Industry funding of patient and health consumer organisations: systematic review with meta-analysis
por: Fabbri, Alice, et al.
Publicado: (2020)

Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare
por: Moynihan, Ray, et al.
Publicado: (2020)

Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry
por: Bartfai, Tamas, et al.
Publicado: (2011)

Tracing the Potential Flow of Consumer Data: A Network Analysis of Prominent Health and Fitness Apps
por: Grundy, Quinn, et al.
Publicado: (2017)

Interacting with the Pharmaceutical Industry
por: Hayden, Stephen R.
Publicado: (2003)

Medicines Information and the Regulation of the Promotion of Pharmaceuticals
por: Leonardo Alves, Teresa, et al.
Publicado: (2018)

Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region
por: Grundy, Quinn, et al.
Publicado: (2022)

Association of food industry ties with findings of studies examining the effect of dairy food intake on cardiovascular disease and mortality: systematic review and meta-analysis
por: Chartres, Nicholas, et al.
Publicado: (2020)

Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis
por: Grundy, Quinn, et al.
Publicado: (2019)

The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures
por: Bero, Lisa, et al.
Publicado: (2018)

Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis
por: Chartres, Nicholas, et al.
Publicado: (2019)

Workforce Asset Management Book of Knowledge
por: Disselkamp, Lisa
Publicado: (2013)

Barriers to Utilizing Non-replacement Male Calves in the Australian Dairy Industry: A Qualitative Study
por: Vicic, Veronika, et al.
Publicado: (2022)

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada
por: Morgan, Steven G., et al.
Publicado: (2016)

Framing overdiagnosis in breast screening: a qualitative study with Australian experts
por: Parker, Lisa M., et al.
Publicado: (2015)

The Devil they Knew: Chemical Documents Analysis of Industry Influence on PFAS Science
por: Gaber, Nadia, et al.
Publicado: (2023)

An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
por: Annabi, Majid, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b9kekj3np0tuhrr40h4trb69r5